| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.8 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.8 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.046 | 0.8 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.8 |